These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7025500)

  • 1. A double-blind trial of O-(beta-hydroxyethyl)-rutoside in patients with chronic venous insufficiency.
    Bergqvist D; Hallböök T; Lindblad B; Lindhagen A
    Vasa; 1981; 10(3):253-60. PubMed ID: 7025500
    [No Abstract]   [Full Text] [Related]  

  • 2. A double blind trial of oral O. B-hydroxyethyl rutosides for stasis leg ulcers.
    Mann RJ
    Br J Clin Pract; 1981 Feb; 35(2):79-81. PubMed ID: 7020736
    [No Abstract]   [Full Text] [Related]  

  • 3. [Dose-response study with O-(beta-hydroxyethyl)-rutoside oral solution].
    Nocker W; Diebschlag W
    Vasa; 1987; 16(4):365-9. PubMed ID: 3321740
    [No Abstract]   [Full Text] [Related]  

  • 4. Paroven in the treatment of chronic venous insufficiency.
    Pulvertaft TB
    Practitioner; 1979 Dec; 223(1338):838-41. PubMed ID: 396527
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical, placebo-controlled double-blind study of venoruton in the treatment of chronic venous insufficiency. Importance of the selection of patients].
    Balmer A; Limoni C
    Vasa; 1980; 9(1):76-82. PubMed ID: 7368843
    [No Abstract]   [Full Text] [Related]  

  • 6. [A 3-month, randomized double-blind dose-response study with 0-(beta-hydroxyethyl)-rutoside oral solutions].
    Nocker W; Diebschlag W; Lehmacher W
    Vasa; 1989; 18(3):235-8. PubMed ID: 2678805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevention of cystoid macular edema with O-beta-hydroxyethyl-rutoside (Venoruton) in a double-blind study].
    Artaria LG
    Klin Monbl Augenheilkd; 1982 Jun; 180(6):568-70. PubMed ID: 6752553
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of 0-(beta-hydroxyethyl)-rutoside (Venoruton) on symptomatic venous insufficiency in the lower limbs].
    Pedersen FM; Hamberg O; Sørensen MD; Neland K
    Ugeskr Laeger; 1992 Sep; 154(38):2561-3. PubMed ID: 1413183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. General practice treatment of symptoms of venous insufficiency with oxerutins. Results of a 660 patient multicentre study in the UK.
    Pulvertaft TB
    Vasa; 1983; 12(4):373-6. PubMed ID: 6362258
    [No Abstract]   [Full Text] [Related]  

  • 10. [Modifications induced by long-term treatment with high doses of 0-(beta-hydroxyethyl)-rutoside in chronic venous insufficiency].
    Barbarino C; Pezzangora V
    Vasa Suppl; 1989; 27():120. PubMed ID: 2623482
    [No Abstract]   [Full Text] [Related]  

  • 11. [Dosage of O-beta hydroxyethylrutoside in chronic venous insufficiency].
    Stemmer R; Furderer CR
    Phlebologie; 1986; 39(4):995-1003. PubMed ID: 3562569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of O-(beta-hydroxyethyl)-rutosides at high dosage in counteracting the unwanted activity of oral contraceptives on venous function.
    Cappelli R; Pecchi S; Oberhauser V; Forconi S; Di Perri T
    Int J Clin Pharmacol Res; 1987; 7(4):291-9. PubMed ID: 3596872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between the efficacy and tolerability of oxerutins and troxerutin in the treatment of patients with chronic venous insufficiency.
    Rehn D; Golden G; Nocker W; Diebschlag W; Lehmacher W
    Arzneimittelforschung; 1993 Oct; 43(10):1060-3. PubMed ID: 8267669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy of O-(beta-hydroxyethyl)-rutosides in the treatment of venous leg ulcers].
    Stegmann W; Hubner K; Deichmann B; Muller B
    Phlebologie; 1987; 40(1):149-56. PubMed ID: 3554278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of the activity of a flavonoid, 3-(beta-hydroxyethyl)-rutoside, at high dose levels on venous tone measured by "strain gauge" plethylsmography.
    Forconi S; Guerrini M; Di Perri T
    Vasa; 1977; 6(3):279-84. PubMed ID: 335696
    [No Abstract]   [Full Text] [Related]  

  • 16. [The behavior of blood clotting and its inhibitors under long term treatment with 5,6-benzo-alpha-pyrone (coumarin). Double blind study].
    Köstering H; Bandura B; Merten HA; Wieding JU
    Arzneimittelforschung; 1985; 35(8):1303-6. PubMed ID: 3907641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of HR (O-(beta-hydroxyethyl)-rutosides) on the impaired venous function of young females taking oral contraceptives. A strain gauge plethysmographic and clinical open controlled study.
    Forconi S; Guerrini M; Pecchi S; Cappelli R; Bruni F
    Vasa; 1980; 9(4):324-30. PubMed ID: 7008418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Critical study of the therapeutic effects of phlebotropic drugs on chronic venous insufficiency].
    Roztocil K; Prerovsky I; Oliva I
    Phlebologie; 1979; 32(4):395-8. PubMed ID: 120945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapeutic investigations with venosan in veinous disease in the legs (author's transl)].
    Juon M; Messelhäuser I
    Schweiz Rundsch Med Prax; 1976 Jun; 65(24):755-8. PubMed ID: 981190
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prevention of radiation-induced skin reactions in breast cancer].
    Pischnamazzadeh M
    Strahlentherapie; 1983 Jan; 159(1):9-12. PubMed ID: 6340249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.